Colinz Laboratories

Colinz Laboratories Dividend

Dividend of Colinz Laboratories (531210.BO) as of Nov 16, 2026.

Dividend

0.00INR

Last updated:

How much dividend does Colinz Laboratories 2026 pay?

According to the latest status from November 2026, Colinz Laboratories paid a total of 0.00 INR per share in dividends within the last 12 months. With the current Colinz Laboratories price of 72.00 INR, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Colinz Laboratories Dividends

Historical Colinz Laboratories Dividends
PaydateDividend

The Colinz Laboratories Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2019
0.00 INR
Jan 1, 2020
0.00 INR
Jan 1, 2021
0.00 INR
Jan 1, 2022
0.00 INR
Jan 1, 2023
0.00 INR
Jan 1, 2024
0.00 INR
Jan 1, 2025
0.00 INR
Jan 1, 2026
0.00 INR
The Colinz Laboratories Dividend history
YEARDividendYoY
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—

Is the Colinz Laboratories Dividend Safe?

Colinz Laboratories has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Colinz Laboratories's Dividend Distributions

Colinz Laboratories’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Colinz Laboratories's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Colinz Laboratories's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Colinz Laboratories’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Colinz Laboratories Stock analysis

What does Colinz Laboratories do? Colinz Laboratories Ltd manufactures pharmaceutical formulations including tablets, capsules, granules, liquid orals, injectables, ointments, and creams. The company markets allopathic and ayurvedic products targeting hypertension, cholesterol, diabetes, piles, pyrexia, and malaria treatments for physicians. Gynecologists receive specialized products for morning sickness, infertility, IUGR, and pregnancy maintenance. Additional offerings include hematinic, antispasmodic, anti-inflammatory/anti-allergic tablets, capsules, gel, and medicated shampoo. Products are sold across Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh, and West Bengal through the company's own marketing team. The firm's revenue streams come from direct sales to healthcare professionals and pharmacies within its operational states. Physicians prescribe products for chronic conditions like hypertension and diabetes, while gynecologists utilize specialized treatments for pregnancy-related issues. The company's product portfolio spans both conventional allopathic medicines and traditional ayurvedic formulations, catering to diverse medical needs. Marketing efforts focus on state-specific distribution through dedicated in-house sales staff. Colinz Laboratories Ltd serves the pharmaceutical market segment with a clear focus on regional healthcare providers. Its product range addresses common health concerns such as cardiovascular issues, metabolic disorders, and pregnancy care. The company's strategy involves direct engagement with medical practitioners to promote its formulations, ensuring consistent market presence in key Indian states without external partnerships or third-party distribution channels. Colinz Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Colinz Laboratories stock

Colinz Laboratories paid dividends every year for the past 0 years.

Colinz Laboratories is assigned to the 'Health' sector.

The dividends of Colinz Laboratories are distributed in INR.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Colinz Laboratories